US 12084514
Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
granted A61KA61K2039/505A61K2039/585
Quick answer
US patent 12084514 (Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/585, A61K2239/31, A61K2239/38